Search Results 61-70 of 24169 for B cell lymphomas

  1. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...

  2. Non Clinical Trials - Mayo Clinic Research

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

  3. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    These conditions include such cancers as multiple myeloma, Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), and such precursor conditions as monoclonal ...

  4. Central Nervous System (CNS) Lymphoma Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have ...

  5. Doctors and departments - Mayo Clinic

    Mayo Clinic doctors and researchers are studying B-cell lymphomas to look for new ways to improve diagnosis and treatment for this cancer. Cancer research is ...

  6. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  7. Burkitt lymphoma - Diagnosis and treatment - Mayo Clinic

    Burkitt lymphoma. Human Pathology. 2024; doi:10.1016/j.humpath.2024.105703. B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org ...

  8. Small lymphocytic lymphoma - Diagnosis and treatment - Mayo Clinic

    A complete blood count may be used to count the number of lymphocytes in a blood sample. A high number of B cells, one type of lymphocyte, could mean small ...

  9. CAR-T cell therapy for lymphoma and other blood cancers at Mayo Clinic in Jacksonville, Florida

    Patients with large B-cell lymphoma who do not respond to an anthracycline-based front-line chemoimmunotherapy or who show evidence of relapse within 12 months ...

  10. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    Clinical Trials · MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL).